DAY 6 – Our Small American Business Is Bleeding Out... Because of Amazon (Case #17718471571)
Today marks Day 6 of one of our core product being removed from Amazon without cause.
We’re a small U.S.-based company and manufacture of health and wellness products.
- Our products are: FDA-registered NDC-listed
- Over-the-Counter (OTC) compliant
- LegitScript-certified
- Sold on Amazon for over 5 years without issue
Suddenly, it was flagged as an “unapproved drug” and taken offline—without anyone reaching out first or reviewing our documentation. We've already submitted proof of compliance, yet we were told we’d have to wait 10 business days just for a review.
That wait is costing us over 50% of our monthly revenue. We’ve had to start sending team members home. This delay affects our ability to serve customers, pay our people, and fulfill long-term subscriptions and multi-channel orders.
It’s not just a listing issue—it’s a small US business issue.
And it’s not just unfair—it’s devastating.
Meanwhile, Amazon allows similar, if the the same OTC products—including their own "Amazon Basics" brand—to remain active.
We’ve done everything right.
We're proud to manufacture in the U.S., follow every regulation, and build trust with thousands of happy customers.
But 6 days of silence is too long.
This is how small businesses are suffocated—not by the market, but by missteps from the very platforms we rely on to reach our customers.
@Yokie_Amazon @Connor_Amazon @LeviDylan_Amazon
– Please help fix this.
Case #17718471571
DAY 6 – Our Small American Business Is Bleeding Out... Because of Amazon (Case #17718471571)
Today marks Day 6 of one of our core product being removed from Amazon without cause.
We’re a small U.S.-based company and manufacture of health and wellness products.
- Our products are: FDA-registered NDC-listed
- Over-the-Counter (OTC) compliant
- LegitScript-certified
- Sold on Amazon for over 5 years without issue
Suddenly, it was flagged as an “unapproved drug” and taken offline—without anyone reaching out first or reviewing our documentation. We've already submitted proof of compliance, yet we were told we’d have to wait 10 business days just for a review.
That wait is costing us over 50% of our monthly revenue. We’ve had to start sending team members home. This delay affects our ability to serve customers, pay our people, and fulfill long-term subscriptions and multi-channel orders.
It’s not just a listing issue—it’s a small US business issue.
And it’s not just unfair—it’s devastating.
Meanwhile, Amazon allows similar, if the the same OTC products—including their own "Amazon Basics" brand—to remain active.
We’ve done everything right.
We're proud to manufacture in the U.S., follow every regulation, and build trust with thousands of happy customers.
But 6 days of silence is too long.
This is how small businesses are suffocated—not by the market, but by missteps from the very platforms we rely on to reach our customers.
@Yokie_Amazon @Connor_Amazon @LeviDylan_Amazon
– Please help fix this.
Case #17718471571
1 reply
Atlas_Amazon
Hello @Seller_Ba2T0rVchj2fw
Case #17718471571
Thank you for the information provided regarding the recent impacts to your account. I know the issue can be increasingly frustrating given the impact to the listing, so I do want to get you moving towards a resolution. I have checked in on the case information that you shared, and did see where our team has been in the process of reviewing the situation. At this time, I do not have any updates available, but I have requested one to be shared so that support can be given. If you observe any changes or receive any new messaging, please refer back to this thread.
Best,
Atlas
